Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Best Biopsy Technique for Small Basal Cell Carcinoma

Critical Depth Requirement

  • The National Comprehensive Cancer Network recommends that biopsy depth must include the deep reticular dermis, regardless of the technique chosen, to capture any infiltrative histology that may be present at the deeper margins 1, 2, 3, 4, 5, 6
  • Infiltrative or aggressive histologic subtypes may only be present at the deeper, advancing margins of the tumor, and superficial biopsies frequently miss these aggressive components, leading to undertreatment 1, 3, 5, 6

Choosing Between Techniques

  • The American Academy of Dermatology suggests that punch biopsy and shave biopsy demonstrate equivalent diagnostic accuracy for correctly identifying BCC histologic subtypes, with a diagnostic accuracy of approximately 75-80% 7, 8, 9
  • Punch biopsy provides full-thickness tissue through dermis into subcutaneous fat, and is particularly useful when deeper invasion is suspected or tumor thickness needs to be assessed 7, 8, 9
  • Deep shave (saucerization) biopsy must be a deep tangential technique to be effective, and is appropriate for raised lesions where a deep scoop into the dermis is possible 7

Critical Pitfall to Avoid

  • The National Comprehensive Cancer Network advises against performing a superficial tangential shave biopsy for suspected BCC, as this can lead to failure to detect aggressive subtypes and underestimation of risk category 1, 3

When to Repeat Biopsy

  • The American Academy of Dermatology recommends considering repeat biopsy if the initial specimen shows tumor transection at the base, or if there is clinical suspicion for aggressive features but the biopsy shows only superficial/nodular subtype 7, 8, 9

Essential Clinical Information to Provide Pathologist

  • The American Academy of Dermatology suggests documenting anatomic location, whether the lesion is primary or recurrent, history of prior radiation, immunosuppression status, and clinical size of the lesion on the requisition to guide treatment selection 3, 7, 8, 9

REFERENCES

1

basal cell and squamous cell skin cancers. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

2

basal cell skin cancer, version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

3

basal cell skin cancer, version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

4

basal cell and squamous cell skin cancers. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

5

basal cell and squamous cell skin cancers. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

6

basal cell and squamous cell skin cancers. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

7
8

guidelines of care for the management of basal cell carcinoma. [LINK]

Journal of the American Academy of Dermatology, 2018

9